Certain anti-cancer medications also target healthy cells in addition to malignant cells. Their use may become restricted if their effects on the latter are excessively powerful. The mechanism of action of PARP inhibitors, which are specifically used for treating breast and ovarian cancer in
London [UK], July 19 (ANI): Non-coding 'junk' DNA, far from being innocuous and inactive, has been discovered by scientists to potentially contribute to the development of cancer.